Shionogi
Clinical trials sponsored by Shionogi, explained in plain language.
-
Hope for rare brain disorder: new drug trial launches
Disease control OngoingThis study tests a drug called zatolmilast in 30 people aged 9 to 45 with Jordan's syndrome, a rare genetic condition that affects brain development. The main goal is to check if the drug is safe and tolerable. Participants will be randomly assigned to receive either the drug or …
Phase: PHASE2 • Sponsor: Shionogi • Aim: Disease control
Last updated May 26, 2026 06:43 UTC
-
New stroke drug shows promise in major trial
Disease control OngoingThis study tests an investigational drug called redasemtide in 680 adults who recently had a stroke caused by a blood clot. Participants receive either the drug or a placebo within 25 hours of their stroke. The main goal is to see if the drug helps improve recovery and daily func…
Phase: PHASE2 • Sponsor: Shionogi • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New drug combo aims to quiet nighttime breathing pauses
Symptom relief OngoingThis study tests three different drugs—sivopixant, acetazolamide, and SASS-001—to see if they can reduce the number of breathing pauses (apneas) during sleep in adults with central sleep apnea. About 60 participants with heart conditions will receive one of the drugs or a placebo…
Phase: PHASE2 • Sponsor: Shionogi • Aim: Symptom relief
Last updated May 19, 2026 11:48 UTC